Showing results (71-80 of 111) with videos related to
Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancerDaniel C Danila, Glenn Heller, Gretchen A Gignac, et al.Oncology|June 17, 2011
Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results?Nancy E Kemeny, Lawrence Schwartz, Mithat Gönen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Dose escalation study of intravenous estramustine phosphate in combination with Paclitaxel and Carboplatin in patients with advanced prostate cancerWilliam Kevin Kelly, Andrew X Zhu, Howard Scher, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 24, 2020
Long-term safety and efficacy of subcutaneous C1-inhibitor in older patients with hereditary angioedemaJonathan A Bernstein, Lawrence Schwartz, William Yang, et al.Clinical Prostate Cancer|January 8, 2005
Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapseDarko Pucar, Jason A Koutcher, Ankoor Shah, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapyMichael J Morris, Timothy Akhurst, Steven M Larson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinomaManish A Shah, Ramesh K Ramanathan, David H Ilson, et al.Gastrointestinal Cancer Research : GCR|January 8, 2013
A Nonrandomized, Phase II Study of Sequential Irinotecan and Flavopiridol in Patients With Advanced Hepatocellular CarcinomaCelina Ang, Eileen M O'Reilly, Richard D Carvajal, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Phase 1 study of aflibercept administered subcutaneously to patients with advanced solid tumorsWilliam P Tew, Michael Gordon, John Murren, et al.Clinical Nuclear Medicine|February 29, 2020
FLT-PET At 6 Weeks Predicts Response Assessed by CT at 12 Weeks in Melanoma Patients Treated With PembrolizumabRandy Yeh, Megan H Trager, Emanuelle M Rizk, et al.Pageof 12